{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:28:50Z","timestamp":1790735330747,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Nahda University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The study of green analytical chemistry has garnered significant attention in the context of mitigating global environmental contamination. In this study, we present two methodologies for environmentally friendly chromatography that enable simultaneous and specific determination of Saxagliptin (SAX), metformin (MET), and a pharmacopoeial impurity of MET known as melamine (MEL). The initial method employed in this study is High-Performance Thin Layer Chromatography (HPTLC), which utilized 60 F 254 silica gel-coated Mark HPTLC plates on aluminum sheets as the stationary phase. The developing system was made up of a mix of ethyl acetate: methanol: ammonia: glacial acetic acid in a ratio of 6:4:1:0.3 (v\/v\/v\/v). The analysis was performed at a wavelength of 215\u00a0nm. The second method employed in this study is ultra-performance liquid chromatography (UPLC). In this method, a C18 column was utilized for the separation process. The mobile phase was made up of a mix of methanol and 0.01\u00a0M sodium dodecyl sulfate, with a pH of 3.3 achieved by adding orthophosphoric acid. The ratio of methanol to sodium dodecyl sulfate in the mobile phase was 70:30 (v\/v). The flow rate of the mobile phase was established at a rate of 1.5\u00a0mL\/min. The peaks found and recorded are resolved at a wavelength of 215\u00a0nm. The three analytes under investigation were successfully separated and assessed using the recommended protocols. Both methods were validated following the International Council for Harmonization (ICH) recommendations for assessing linearity, range, accuracy, precision, specificity, and robustness. Moreover, the environmental sustainability of the advanced methodologies The assessment has been performed using various instruments, such as the Analytical Eco-Scale, NEMI, GAPI, and AGREE. The utilization of these tools was implemented in order to perform a comprehensive assessment of the environmental sustainability of the methods, as well as to establish a comparison with previously documented approaches. This study was carried out to evaluate the potential environmental implications of the suggested methods and to determine their suitability for concurrent analysis of the examined pharmaceuticals in formula and quality control units.<\/jats:p>","DOI":"10.1186\/s13065-025-01385-6","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T02:38:23Z","timestamp":1738031903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sequential separation of anti-diabetic drugs in the presence of melamine as impurity using chromatographic methods"],"prefix":"10.1186","volume":"19","author":[{"given":"Maimana A.","family":"Magdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M.","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa G.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal B.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"1385_CR1","first-page":"789","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"L Brunton","year":"2006","unstructured":"Brunton L, et al. Renin and angiotensin. In: Brunton LL, Chabner B, Knollmann BC, editors., et al., Goodman & Gilman\u2019s the pharmacological basis of therapeutics, vol. 11. New York: McGraw-Hill; 2006. p. 789\u2013821."},{"issue":"15","key":"1385_CR2","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1021\/jm050261p","volume":"48","author":"DJ Augeri","year":"2005","unstructured":"Augeri DJ, et al. Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J Med Chem. 2005;48(15):5025\u201337.","journal-title":"J Med Chem"},{"key":"1385_CR3","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jep.2014.07.020","volume":"158","author":"A-S Bouin","year":"2014","unstructured":"Bouin A-S, Wierer M. Quality standards of the European pharmacopoeia. J Ethnopharmacol. 2014;158:454\u20137.","journal-title":"J Ethnopharmacol"},{"key":"1385_CR4","unstructured":"Indian Pharmacopoeia, Indian Pharmacopoeia Commission, Ghaziabad. Govt. of India Ministry of Health and Family Welfare. 2010; 2:1451."},{"issue":"8","key":"1385_CR5","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.3390\/nu13082742","volume":"13","author":"HA Oketch-Rabah","year":"2021","unstructured":"Oketch-Rabah HA, et al. United States Pharmacopeia (USP) safety review of gamma-aminobutyric acid (GABA). Nutrients. 2021;13(8):2742.","journal-title":"Nutrients"},{"key":"1385_CR6","unstructured":"Thermo Fisher Scientific. Residual solvent analysis application note. 2018. https:\/\/assets.thermofisher.com\/TFS-Assets\/CMD.Application-Notes\/an-10676-hsgc-residual-solvents-pharmaceuticals-an10676-en.pdf. Accessed 1 Jan 2025."},{"issue":"2","key":"1385_CR7","first-page":"19","volume":"3","author":"N Nyola","year":"2012","unstructured":"Nyola N, Jeyabalan GS. Development and validation of UV-vis specctroscopy method for simultaneous estimation of Saxagliptin hydrochloride and metformin hydrochloride in active pharmaceutical ingrident. J Pharm Educ Res. 2012;3(2):19.","journal-title":"J Pharm Educ Res"},{"issue":"4","key":"1385_CR8","first-page":"31","volume":"3","author":"P Cholke","year":"2018","unstructured":"Cholke P, et al. Development and validation of UV-Visible spectroscopy method for simultaneous estimation of Saxagliptin hydrochloride and metformin hydrochloride in tablet dosage form. Development. 2018;3(4):31\u20134.","journal-title":"Development"},{"issue":"11","key":"1385_CR9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.4236\/ajac.2015.611080","volume":"6","author":"P Prasad","year":"2015","unstructured":"Prasad P, Satyanaryana K, Krishnamohan G. Development and validation of a method for simultaneous determination of metformin and Saxagliptin in a formulation by RP-HPLC. Am J Anal Chem. 2015;6(11):841.","journal-title":"Am J Anal Chem"},{"key":"1385_CR10","first-page":"70","volume":"4","author":"N Narendra","year":"2012","unstructured":"Narendra N, Jeyabalan G. Simultaneous estimation of Saxagliptin hydrochloride and metformin hydrochloride in active pharmaceutical ingrident by RP-HPLC. Asian J Pharm Res Health Care. 2012;4:70\u20137.","journal-title":"Asian J Pharm Res Health Care"},{"issue":"2","key":"1385_CR11","first-page":"3284","volume":"20","author":"A Kaushal","year":"2020","unstructured":"Kaushal A, et al. A cost effective RP-HPLC method for simultaneous quantitative analysis of Saxagliptin and metformin hydrochloride. Plant Arch. 2020;20(2):3284\u201391.","journal-title":"Plant Arch"},{"issue":"1","key":"1385_CR12","first-page":"381","volume":"5","author":"A Prasanna","year":"2015","unstructured":"Prasanna A, Priyanka K. Method development and validation of simultaneous determination of metformin and Saxagliptin in pharmaceutical dosage form by RP-HPLC. Int J Pharm Chem Biol Sci. 2015;5(1):381.","journal-title":"Int J Pharm Chem Biol Sci"},{"key":"1385_CR13","first-page":"2","volume":"12","author":"S Caglar","year":"2014","unstructured":"Caglar S, Alp A. A validated high performance liquid chromatography method for the determination of Saxagliptin and metformin in bulk, a stability indicating study. J Anal Bioanal Tech. 2014;12:2\u20134.","journal-title":"J Anal Bioanal Tech"},{"issue":"2","key":"1385_CR14","first-page":"311","volume":"55","author":"HA Merey","year":"2017","unstructured":"Merey HA, et al. Chromatographic methods for the simultaneous determination of binary mixture of Saxagliptin HCl and Metformin HCl. Bull Fac Pharm Cairo Univ. 2017;55(2):311\u20137.","journal-title":"Bull Fac Pharm Cairo Univ"},{"key":"1385_CR15","unstructured":"Rao NS, Venkataramana K, Anitha P. Stability-indicating RP-HPLC method and its validation for analysis of Metformin hydrochloride & Saxagliptin in bulk and pharmaceutical dosage form. 2014."},{"key":"1385_CR16","first-page":"1549","volume":"3","author":"AK Bondu","year":"2014","unstructured":"Bondu AK, et al. Method development and validation of Metformin hydrochloride and Saxagliptin by RP-HPLC. World J Pharm Res. 2014;3:1549\u201357.","journal-title":"World J Pharm Res"},{"issue":"1","key":"1385_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.kijoms.2015.06.002","volume":"1","author":"SN Konari","year":"2015","unstructured":"Konari SN, Jacob JT. Stability indicating validated RP-HPLC technique for the analysis of multicomponent anti-diabetic drug combos in pharmaceutical dosage forms. Karbala Int J Mod Sci. 2015;1(1):39\u201348.","journal-title":"Karbala Int J Mod Sci"},{"issue":"10","key":"1385_CR18","first-page":"23","volume":"3","author":"R Surisetti","year":"2018","unstructured":"Surisetti R, Nagaraju K. Analytical method development and validation for the estimation of Saxagliptin and Metformin by RP HPLC method. Int J Adv Res Dev. 2018;3(10):23\u20138.","journal-title":"Int J Adv Res Dev"},{"key":"1385_CR19","unstructured":"Maduraivoyal C. A validated RP\u2013HPLC method for simultaneous estimation of metformin and Saxagliptin in tablets. 2012."},{"issue":"9","key":"1385_CR20","first-page":"110","volume":"11","author":"PM Kharabe","year":"2021","unstructured":"Kharabe PM, Kadam DK. Strong cation exchange chromatography: a new option for concurrent quantification of Saxagliptin and metformin. J Appl Pharm Sci. 2021;11(9):110\u20137.","journal-title":"J Appl Pharm Sci"},{"key":"1385_CR21","doi-asserted-by":"publisher","first-page":"s350","DOI":"10.5530\/ijper.54.2s.93","volume":"54","author":"SB Gurav","year":"2020","unstructured":"Gurav SB, Manish N. Development and validation of novel stability-indicating LC method for the determination of Saxagliptin and metformin. Indian J Pharm Educ Res. 2020;54:s350\u20137.","journal-title":"Indian J Pharm Educ Res"},{"key":"1385_CR22","first-page":"2729","volume":"12","author":"RP Umbarkar","year":"2022","unstructured":"Umbarkar RP, Mittal A, Charde MS. Validated stability-indicating assay UHPLC method for simultaneous analysis of Saxagliptin and metformin in fixed-dose combinations. Biointerface Res Appl Chem. 2022;12:2729\u201344.","journal-title":"Biointerface Res Appl Chem"},{"issue":"6","key":"1385_CR23","first-page":"593","volume":"67","author":"G Klaczkow","year":"2010","unstructured":"Klaczkow G, Anuszewska EL. Determination of impurities in medical products containing metformin hydrochloride. Acta Pol Pharm. 2010;67(6):593\u20138.","journal-title":"Acta Pol Pharm"},{"key":"1385_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1556\/1006.2019.32.4.5","volume":"32","author":"NS Abdelwahab","year":"2019","unstructured":"Abdelwahab NS, et al. Different chromatographic methods for the determination of antidiabetic drugs in the presence of drug toxic impurity. J Planar Chromatogr Modern TLC. 2019;32:309\u201316.","journal-title":"J Planar Chromatogr Modern TLC"},{"issue":"3","key":"1385_CR25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1080\/22297928.2019.1622450","volume":"9","author":"NS Abdelhamid","year":"2019","unstructured":"Abdelhamid NS, et al. Simultaneous determination of repaglinide, metformin hydrochloride and melamine by new HPLC and HPTLC chromatographic methods. Anal Chem Lett. 2019;9(3):418\u201329.","journal-title":"Anal Chem Lett"},{"key":"1385_CR26","unstructured":"ICH. I. Q2 (R1): Validation of analytical procedures: text and methodology. In: International conference on harmonization, Geneva. 2005."},{"issue":"05","key":"1385_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4155\/bio-2018-0191","volume":"11","author":"MY Fares","year":"2019","unstructured":"Fares MY, et al. Determination of sofosbuvir with two co-administered drugs; paracetamol and DL-methionine by two chromatographic methods: application to a pharmacokinetic study. Bioanalysis. 2019;11(05):349\u201364.","journal-title":"Bioanalysis"},{"issue":"9","key":"1385_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4598","volume":"33","author":"NS Abdelwahab","year":"2019","unstructured":"Abdelwahab NS, et al. Different stability-indicating chromatographic methods for specific determination of paracetamol, dantrolene sodium, their toxic impurities and degradation products. Biomed Chromatogr. 2019;33(9): e4598.","journal-title":"Biomed Chromatogr"},{"issue":"5","key":"1385_CR29","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/jaoac\/94.5.1427","volume":"94","author":"SS Abbas","year":"2011","unstructured":"Abbas SS, et al. Simultaneous determination of diloxanide furoate and metronidazole in presence of diloxanide furoate degradation products. J AOAC Int. 2011;94(5):1427\u201339.","journal-title":"J AOAC Int"},{"key":"1385_CR30","first-page":"426","volume":"3","author":"A Mukherjee","year":"2012","unstructured":"Mukherjee A, Bera A. A detailed study of validation parameters and system suitability test in HPLC. Res J Pharm Bio Chem Sci. 2012;3:426\u201347.","journal-title":"Res J Pharm Bio Chem Sci"},{"issue":"9","key":"1385_CR31","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires DE, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58(9):4066\u201372.","journal-title":"J Med Chem"},{"issue":"6","key":"1385_CR32","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1021\/cr068359e","volume":"107","author":"LH Keith","year":"2007","unstructured":"Keith LH, Gron LU, Young JL. Green analytical methodologies. Chem Rev. 2007;107(6):2695\u2013708.","journal-title":"Chem Rev"},{"key":"1385_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","volume":"37","author":"A Ga\u0142uszka","year":"2012","unstructured":"Ga\u0142uszka A, et al. Analytical Eco-Scale for assessing the greenness of analytical procedures. TrAC Trends Anal Chem. 2012;37:61\u201372.","journal-title":"TrAC Trends Anal Chem"},{"issue":"6","key":"1385_CR34","doi-asserted-by":"publisher","first-page":"10928","DOI":"10.3390\/molecules200610928","volume":"20","author":"M Tobiszewski","year":"2015","unstructured":"Tobiszewski M, et al. Green chemistry metrics with special reference to green analytical chemistry. Molecules. 2015;20(6):10928\u201346.","journal-title":"Molecules"},{"key":"1385_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.teac.2023.e00202","volume":"38","author":"MS Imam","year":"2023","unstructured":"Imam MS, Abdelrahman MM. How environmentally friendly is the analytical process? A paradigm overview of ten greenness assessment metric approaches for analytical methods. Trends Environ Anal Chem. 2023;38: e00202.","journal-title":"Trends Environ Anal Chem"},{"key":"1385_CR36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","volume":"181","author":"J P\u0142otka-Wasylka","year":"2018","unstructured":"P\u0142otka-Wasylka J. A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index. Talanta. 2018;181:204\u20139.","journal-title":"Talanta"},{"issue":"14","key":"1385_CR37","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira F, Wojnowski W, Tobiszewski M. AGREE\u2014Analytical GREEnness metric approach and software. Anal Chem. 2020;92(14):10076\u201382.","journal-title":"Anal Chem"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01385-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-025-01385-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01385-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T02:38:34Z","timestamp":1738031914000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-025-01385-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1385"],"URL":"https:\/\/doi.org\/10.1186\/s13065-025-01385-6","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"22 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}